Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BioCryst ( (BCRX) ) just unveiled an update.
BioCryst Pharmaceuticals will present at the J.P. Morgan Healthcare Conference on January 14, 2025, highlighting its drug discovery and development programs. The company emphasizes the importance of its Investor Relations website for accessing material information, aligning with its disclosure obligations.
More about BioCryst
BioCryst Pharmaceuticals, Inc. operates in the biotechnology industry, focusing on the discovery and development of novel oral drugs for rare diseases.
YTD Price Performance: -2.04%
Average Trading Volume: 2,064,464
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $1.59B
Find detailed analytics on BCRX stock on TipRanks’ Stock Analysis page.